Patrick Rose is Innovation Manager at the German Federal Agency for Disruptive Innovation, SPRIND. Since December 2022, he has been building an investment portfolio with an emphasis on biotechnology. Previously, Patrick was the inaugural Science Director for Synthetic Biology at the United States Office of Naval Research Global (ONRG), where he built the first synthetic biology focused global investment portfolio in early research. Later he was named Chief Scientist at ONRG and was responsible for all Science Directors and their investments in the Americas, Africa, Middle East, and Europe. While working for ONRG, Patrick was also selected to be the inaugural Program Manager for the United States Department of Defense Bioindustrial Manufacturing Innovation Institute; later selected to be BioMADE. He led the team to establish the institute and manage its operations the first three years, while executing the strategic biomanufacturing priorities for the United States Department of Defense Manufacturing Technologies Office. Patrick has spent most of his career looking at the potential of technology and its risk and consequences from various perspectives. He holds a PhD in microbiology from Oregon Health & Science University and is an inaugural alumnus of the Johns Hopkins Center for Health Security Emerging Leaders in Biosecurity Program.

‍